Main Menu

Press Archive

2017 Press Archive

Immune system genes linked to leukaemia, largest ever brain cancer study, ASCO 2017 conference, and new genetic cause of kidney cancer in children identified.

Find out more

2016 Press Archive

The London Cancer Hub announced, new research strategy, BBC 'Shine a light on cancer', MR Linac launch with Mayor of London

Find out more

2015 Press Archive

BBC Panorama appearance, manipulating cell shape and a new role for an 'old' cancer gene.

Find out more

2014 Press Archive

Launching The Centre for Evolution and Cancer, the ICR brought experts in the methods and theories of Evolutionary Biology into their multidisciplinary cancer research team.

Read more

2013 Press Archive

The ICR began a a new push to bring personalised treatments to patients, with its Tumour Profiling Unit.

Read more

2012 Press Archive

ICR-developed drug abiraterone was recommended for prostate cancer patients on the NHS, and the ICR opened the Centre for Molecular Pathology.

Read more

2011 Press Archive

Europe's leading cancer research centre, The Institute of Cancer Research (ICR), named eminent scientist Professor Alan Ashworth as its new Chief Executive.

Read more

2010 Press Archive

Phase III trial results showed that the drug abiraterone, developed at the ICR, can significantly extend overall survival for men with advanced prostate cancer.

Read more

2009 Press Archive

2009 marked the centenary year for the ICR, which began life as a small research laboratory in the Royal Marsden Hospital.

Read more

2008 Press Archive

The ICR announced that the drug abiraterone could treat up to 80% of patients with aggressive and previously drug resistant prostate cancer.

Read more

2007 Press Archive

ICR scientists identified two common genetic variants that could triple a person’s risk of getting bowel cancer.

Read more

2006 Press Archive

The complex chain of molecular triggers involved in the development of malignant melanoma, the deadliest form of skin cancer, was published by the ICR.

Read more
We use cookies to ensure that we give you the best experience on our website. By continuing to use this website, you are agreeing to our use of cookies on your device as described in our cookie policy. You can change your cookie settings at any time but parts of our site will not function correctly without them.